[1] Xu X,Nie S,Liu Z,et al.Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults[J].Clinical Jjournal of the American Society of Nephrology:CJASN,2015,10(9):1510-1518. [2] Yang L,Xing G,Wang L,et al.Acute kidney injury in China:a cross-sectional survey[J].Lancet,2015,386(10002):1465-1471. [3] National Adverse Drug Reaction Monitoring Center.Guidelines for the use of adverse drug reaction terms(Monitoring and Evaluation Comprehensive [2016] No.77)[S].BeijJing:National Adverse Drug Reaction Monitoring Center(国家药品不良反应监测中心),2016:80-83. [4] Khan S,Loi V,Rosner MH,et al.Drug-Induced Kidney Injury in the Elderly[J].Drugs &Aging,2017,34(10):729-741. [5] Fan QQ,Kong XD,Deng A,et al.Study Progress of Drug-Induced Acute Kidney Injury[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2015,12(3):164-168. [6] Boddu R,Fan C,Rangarajan S,et al.Unique sex- and age-dependent effects in protective pathways in acute kidney injury[J].American Jjournal of Pphysiology Renal Pphysiology,2017,313(3):F740-F755. [7] Zhao L,Guo DH,Zhu M,et al.Analysis of 501 Cases of Drug-induced Kidney Injury[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2015,12(10):627-631. [8] Wang DX,Zhu M,Guo DH,et al.Analysis on 930 cases of ADR/ADE associated with glycopeptides and oxazolidinone antibacterials from military hospitals[J].Chinese Journal of Drug Application and Monitoring(中国药物应用与监测),2017,14(1):37-40,41. [9] Welch HK,Kellum JA,Kane-Gill SL.Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Admin-istration Adverse Event Reporting System Database[J].Pharmaco-therapy,2018,38(8):785-793. [10] Hosohata K,Inada A,Oyama S,et al.Surveillance of drugs that most frequently induce acute kidney injury:A pharmacovigilance approach[J].Journal of Cclinical Ppharmacy and Ttherapeutics,2019,44(1):49-53. [11] Zhu M,Cai L,Guo DH,et al.Analysis on 209 Adverse Drug Reaction/Event Cases of Anti-infective Agents Induced Kidney Injury[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2015,24(9):537-540. [12] Pan KM,Wu Y,Chen C,et al.Vancomycin-induced acute kidney injury in elderly Chinese patients:a single-centre cross-sectional study[J].Br J Clin Pharmacol,2018,84(8):1706-1718. [13] Ye ZK,Tang HL,Zhai SD.Benefits of Therapeutic Drug Monitoring of Vancomycin:A Systematic Review and Meta-Analysis[J].Plos One,2013,8(10):e77169. [14] Dong D,Mao L,Song F,et al.Establishment and evaluation of a method for norvancomycin concentration determination in human plasma[J].Chinese Journal of Drug Application and Monitoring(中国药物应用与监测),2019,16(3):146-149. [15] Lian XJ,Chen YH,Lin JS,et al.Clinical characteristics and medications for hospital-acquired acute kidney injury in the elderly patients[J].Chinese Journal of Multiple Organ Diseases in the Elderly(中华老年多器官疾病杂志),2018,17(12):901-905. [16] Mehran R,Dangas GD,Weisbord SD.Contrast-Associated Acute Kidney Injury[J].The New England Jjournal of Mmedicine,2019,380(22):2146-2155. [17] Wang SQ,Wang AD.Effects of Ioversol,Iodixanol,Iopromide on Renal Function in Patients with Early Diabetic Nephropathy[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2019,16(4):199-202. [18] Cai L,Zhu M,Guo DH,et al.Analysis of Anti-infectious Agents Related Hepatic Adverse Drug Reactions based on Data Mining Methods[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2016,25(2):25-29. [19] Yu C,Xu YM,Zhou J,et al.Study on Signal Detection of Xiyanping Injection-induced Urticaria Based on BCPNN Warning Technology[J].China Pharmacy(中国药房),2017,28(14):1921-1924. [20] Guo DH,Chen C,Ma L,et al.Analysis on 67826 ADR reports of the military hospitals from 2009 to 2013[J].Chinese Journal of Drug Application and Monitoring(中国药物应用与监测),2014,11(5):300-304. [21] Chen C,Jia WP,Guo DH,et al.Development of a Computer-Assisted Adverse Drug Events Alarm and Assessment System for Hospital Inpatients in China[J].Therapeutic Innovation &Regulatory Science,2018,18:216847901881019. [22] Guo DH,Hu PZ,Jia WP,et al.Practice and process specification of real-world safety evaluation for large sample population used drugs based on electronic medical record[J].Chinese Journal of Drug Application and Monitoring(中国药物应用与监测),2019,16(3):127-131. |